UT Austin Opens Lab Crucial to Drug Development Process
AUSTIN — The University of Texas at Austin is opening a laboratory that fills a critical gap in the process of developing new drugs and biotechnology products.
AUSTIN — The University of Texas at Austin is opening a laboratory that fills a critical gap in the process of developing new drugs and biotechnology products.
Living donors fare well following liver transplantationMedical XpressResearchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation (LDLT) was better than the general Japanese population …
Miley Turbitt, from South Shields, is at the top of the European transplant list after being diagnosed with a rare heart condition.
Optimer Pharmaceuticals has started an advanced trial of its drug Dificid to prevent C. diff diarrhea in bone marrow transplant patients.
Living donors fare well following liver transplantationScience CodexResearchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation (LDLT) was better than the general Japanese population (…
BBC NewsMSPs give personal testimonies in organ donor debateBBC NewsMSPs have given emotional testimonies in a debate on whether there should be presumed consent for organ donation. Labour member Mark Griffin spoke about the death of his father followi…
( Wiley ) Researchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation was better than the general Japanese population (the norm). This study–one of the largest to date–found that don…
Living donors fare well following liver transplantationEurekAlert (press release)Researchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation (LDLT) was better than the general Japanese…
Medgadget.comBoston Scientific's SYNERGY Everolimus-Eluting Stent Cleared in EuropeMedgadget.comBoston Scientific received CE Mark approval and is gearing up for a limited European market release of its SYNERGY Everolimus-Eluting Platinum Chromium …
Beacon NewsFlashes – November 1, 2012The MDS BeaconNose Tube Feeding May Lead To Better Outcome For MDS Patients Receiving Stem Cell Transplant – Results of recent French study show that nose tube feeding may lead to better outcome for myelodysplas…